Management of the website has been transferred from NHMRC to the Commonwealth Department of Health. Disruption to site users as a consequence of this change should be minimal.

Clinical Trial Details

The role of vitamin D in the treatment of nerve pain in diabetes

Print record Print record
Trial Information

Broad Health Condition Metabolic and Endocrine

Specific Health ConditionDiabetes
Other neurological disorders

Trial FocusTreatment

Recruitment statusRecruiting


Anticipated date of first participant enrolment1/04/2010

Anticipated date of last participant enrolment1/04/2010

Phase of TrialPhase 2 / Phase 3

Has the study received ethics approval?Further information iconApproved

Trial summary

Vitamin D deficiency is common amongst people with type 2 diabetes. People with type 2 diabetes frequently develop painful neuropathy ("nerve pain" especially in the feet). The study hypothesis is that vitamin D supplementation may improve symptoms of nerve pain. The study is therefore designed to investigate the impact of vitamin D supplementation on nerve pain in people with type 2 diabetes

Key inclusion criteria

Patients with type 2 diabetes and with painful neuropathy with a serum 25-hydroxyvitamin D level of less than 50 nmol/L

Minimum age40 Years

Maximum age80 Years

GenderBoth males and females

Can Healthy volunteers participate?No

Key exclusion criteria

Patients with type 1 or secondary diabetes, hypercalcaemia or renal stone
Contact details and further information

Sponsor Primary Sponsor Type: Hospital
Primary Sponsor Name: St Vincent's Hospital
Primary Sponsor Address: 390 Victoria Street, Darlinghurst NSW 2010
Primary Sponsor Country: Australia

Trial IDACTRN12610000322033

Contact person for information and recruitment
Paul Lee
Department of Endocrinology Garvan Institute of Medical Research 384 Victoria Street Darlinghurst New South Wales 2010
+61 2 9295 8486
+61 2 9295 8481
Further information